Warren E. Glaab

2.5k total citations
53 papers, 1.7k citations indexed

About

Warren E. Glaab is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Warren E. Glaab has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Warren E. Glaab's work include DNA Repair Mechanisms (12 papers), Chronic Kidney Disease and Diabetes (9 papers) and Genetic factors in colorectal cancer (9 papers). Warren E. Glaab is often cited by papers focused on DNA Repair Mechanisms (12 papers), Chronic Kidney Disease and Diabetes (9 papers) and Genetic factors in colorectal cancer (9 papers). Warren E. Glaab collaborates with scholars based in United States, France and United Kingdom. Warren E. Glaab's co-authors include Frank D. Sistare, Thomas R. Skopek, Kateřina Vlasáková, Kenneth R. Tindall, Nagaraja Muniappa, Joseph F. Sina, Asad Umar, John I. Risinger, J. Carl Barrett and Thomas A. Kunkel and has published in prestigious journals such as Journal of Biological Chemistry, Genetics and Kidney International.

In The Last Decade

Warren E. Glaab

51 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Warren E. Glaab United States	21	974	720	367	206	187	53	1.7k
Frank Staedtler Switzerland	21	781 0.8×	288 0.4×	91 0.2×	172 0.8×	198 1.1×	49	1.6k
Varsha Kaushal United States	20	656 0.7×	180 0.3×	401 1.1×	253 1.2×	155 0.8×	31	1.5k
Nagaraja Muniappa United States	17	694 0.7×	450 0.6×	91 0.2×	75 0.4×	381 2.0×	24	1.7k
Karol L. Thompson United States	24	857 0.9×	228 0.3×	93 0.3×	169 0.8×	231 1.2×	49	1.6k
Ya Wang China	26	1.2k 1.2×	467 0.6×	99 0.3×	378 1.8×	84 0.4×	89	2.0k
Wei Meng China	20	1.0k 1.1×	448 0.6×	98 0.3×	156 0.8×	74 0.4×	45	1.7k
Tara McMorrow Ireland	24	717 0.7×	172 0.2×	134 0.4×	108 0.5×	232 1.2×	53	1.5k
Grazia Serino Italy	27	1.1k 1.1×	566 0.8×	168 0.5×	201 1.0×	460 2.5×	72	2.3k
Jing Xiong China	24	677 0.7×	170 0.2×	187 0.5×	260 1.3×	303 1.6×	92	1.6k

Countries citing papers authored by Warren E. Glaab

Since Specialization

Citations

This map shows the geographic impact of Warren E. Glaab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren E. Glaab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren E. Glaab more than expected).

Fields of papers citing papers by Warren E. Glaab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren E. Glaab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren E. Glaab. The network helps show where Warren E. Glaab may publish in the future.

Co-authorship network of co-authors of Warren E. Glaab

This figure shows the co-authorship network connecting the top 25 collaborators of Warren E. Glaab. A scholar is included among the top collaborators of Warren E. Glaab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren E. Glaab. Warren E. Glaab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zabka, Tanja S., Michael Lawton, Tom Chu, et al.. (2025). Biomarkers of Drug‐Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug Development. Clinical Pharmacology & Therapeutics. 119(3). 608–617.

Vlasáková, Kateřina, Sean P. Troth, Frank D. Sistare, et al.. (2024). Magnitude of Urine Albumin and KIM-1 Changes Can be Used to Differentiate Glomerular Injury From Tubular Injury in Rats. Toxicologic Pathology. 52(2-3). 88–98. 2 indexed citations

Vlasáková, Kateřina, et al.. (2024). Performance of biomarkers NF-L, NSE, Tau and GFAP in blood and cerebrospinal fluid in rat for the detection of nervous system injury. Frontiers in Neuroscience. 17. 1285359–1285359. 10 indexed citations

Vlasáková, Kateřina, Paul J. Ciaccio, Roger Smith, et al.. (2023). Early-Onset albuminuria and Associated Renal Pathology in Leucine-Rich Repeat Kinase 2 Knockout Rats. Toxicologic Pathology. 51(1-2). 15–26. 3 indexed citations

Balayssac, David, Jérôme Busserolles, Damien Richard, et al.. (2023). Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project. Biomedicine & Pharmacotherapy. 167. 115535–115535. 5 indexed citations

Vlasáková, Kateřina, Wendy J. Bailey, Zoltán Erdős, et al.. (2022). Plasma biomarkers TAP, CPA1, and CPA2 for the detection of pancreatic injury in rat: the development of a novel multiplex IA-LC-MS/MS assay and biomarker performance evaluation. Archives of Toxicology. 97(3). 769–785. 3 indexed citations

Handt, Larry, Kateřina Vlasáková, Vasudevan Bakthavatchalu, et al.. (2021). Kidney Injury Monitoring in Tobramycin-Treated Rhesus Monkeys: Supplementing Urinary Kidney Biomarkers With Kidney Biopsy Gene Expression Profiling. Toxicologic Pathology. 50(1). 35–46. 1 indexed citations

Zabka, Tanja S., John E. Burkhardt, William J. Reagan, et al.. (2020). The use of emerging safety biomarkers in nonclinical and clinical safety assessment – The current and future state: An IQ DruSafe industry survey. Regulatory Toxicology and Pharmacology. 120. 104857–104857. 2 indexed citations

Vlasáková, Kateřina, Sean P. Troth, Frank D. Sistare, & Warren E. Glaab. (2020). Evaluation of 10 Urinary Biomarkers for Renal Safety With 5 Nephrotoxicants in Nonhuman Primates. Toxicologic Pathology. 48(5). 633–648. 8 indexed citations

10.

Aslamkhan, Amy G., Qiuwei Xu, Stephen Pacchione, et al.. (2020). Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice. Toxicology and Applied Pharmacology. 406. 115216–115216. 6 indexed citations

11.

Vlasáková, Kateřina, et al.. (2016). Response of Novel Skeletal Muscle Biomarkers in Dogs to Drug-Induced Skeletal Muscle Injury or Sustained Endurance Exercise.. Toxicological Sciences. 156(2). kfw262–kfw262. 14 indexed citations

12.

Burch, Peter M., Warren E. Glaab, Daniel Holder, et al.. (2016). Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive Performance. Toxicological Sciences. 156(1). kfw225–kfw225. 23 indexed citations

13.

Burch, Peter M., Elizabeth G. Walker, William M. Bracken, et al.. (2015). Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats. Toxicological Sciences. 150(1). 247–256. 35 indexed citations

14.

Bailey, Wendy J., Dan Holder, Hima Patel, et al.. (2012). A Performance Evaluation of Three Drug-Induced Liver Injury Biomarkers in the Rat: Alpha-Glutathione S-Transferase, Arginase 1, and 4-Hydroxyphenyl-Pyruvate Dioxygenase. Toxicological Sciences. 130(2). 229–244. 38 indexed citations

15.

Vaidya, Vishal S., Glen Ford, Sushrut S. Waikar, et al.. (2009). A rapid urine test for early detection of kidney injury. Kidney International. 76(1). 108–114. 165 indexed citations

16.

Glaab, Warren E., et al.. (2005). 5-Fluorouracil forward mutation assay in Salmonella: Determination of mutational target and spontaneous mutational spectra. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 578(1-2). 238–246. 11 indexed citations

17.

Skopek, Thomas R., et al.. (1999). Analysis of sequence alterations in a defined DNA region: comparison of temperature-modulated heteroduplex analysis and denaturing gradient gel electrophoresis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 430(1). 13–21. 12 indexed citations

18.

Glaab, Warren E., Kenneth R. Tindall, & Thomas R. Skopek. (1999). Specificity of mutations induced by methyl methanesulfonate in mismatch repair-deficient human cancer cell lines. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 427(2). 67–78. 39 indexed citations

19.

Umar, Asad, John I. Risinger, Warren E. Glaab, et al.. (1998). Functional Overlap in Mismatch Repair by Human MSH3 and MSH6. Genetics. 148(4). 1637–1646. 122 indexed citations

20.

Tindall, Kenneth R., Warren E. Glaab, Asad Umar, et al.. (1998). Complementation of mismatch repair gene defects by chromosome transfer. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 402(1-2). 15–22. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact